After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has ...
The FDA has approved a fixed-dose triple combination therapy for the maintenance treatment of asthma in adults and children aged 12 years and older, according to a press release from manufacturer ...
Experts say the shortage of the asthma and COPD medication albuterol is likely to get worse in the coming months. One of the largest manufacturers of albuterol, Akorn Pharmaceuticals, filed for ...
Hosted on MSN
Breathe easier with the right asthma plan
Asthma and COPD can make every breath feel like a challenge, but the right treatment plan changes everything. From quick-relief inhalers to daily controllers and advanced biologics, knowing your ...
Inhalers and nebulizers are necessary when managing chronic obstructive pulmonary disease (COPD). Both are designed to deliver medication directly to the lungs, which helps in reducing symptoms, ...
Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
Please provide your email address to receive an email when new articles are posted on . Morning use of once-daily controller medications for asthma and COPD was common and associated with higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results